A multi-centric, comparative, randomized, double blind, parallel group, phase III clinical trial study to evaluate efficacy, safety & tolerability of the continuous intravenous infusion of Tramadol Infusion 0.1 % w/v versus Tramadol 50 mg/ ml injection for the treatment of patients with postoperative pain

Akums Drugs Pharmaceutical Ltd India0 个研究点目标入组 0 人开始时间: 待定最近更新: 2021年11月24日

研究概览

暂无简介。

•1 Patients of ASA(American Society of Anesthesiologists) physical status I and II determined to undergo elective surgery of any etiology under general anesthesia (Hip/Knee Arthroplasty, Open Cholecystectomy).
•2 Hospital stay at least for 24 hours is needed.
•3 Cooperative and understanding skills.
•4 Agreement to informed consent form.

•1 Hypersensitivity to any of the drugs components or other drug from same class.
•2 Patient unable to refrain from alcohol, psychoactive drugs, and sedatives including sleeping preparations (e.g. benzodiazepines) for the duration of their participation in the study
•3 Patient with history of drug of abuse.
•4 Patients at risk for respiratory depression, patients with increased intracranial pressure or head injury, suffering from severe headache.
•5 Pregnant and lactating woman

发起方

Akums Drugs Pharmaceutical Ltd India